Estimation of efficacy and safety of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in recurrent or metastatic breast cancer patients

被引：0
|
作者：
Kang, S. S. [1 ]
Lee, H. [1 ]
Hur, M. [1 ]
Ko, S. [1 ]
Yoon, C. [1 ]
Kang, S. [1 ]
Roh, J. [2 ]
机构：
[1] Dankook Univ, Cheil Gen Hosp, Surg, Seoul, South Korea
[2] Dankook Univ, Cheil Gen Hosp, Med Oncol, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
368
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of the treatment with Nab-paclitaxel in mEtastatic bREast cancer In elDerly patiEnts: NEREIDE study
    Adamo, V.
    Ricciardi, G.
    Schifano, S.
    Russo, A.
    Gebbia, V.
    Blasi, L.
    Giuffrida, D.
    Scandurra, G.
    Savarino, A.
    Butera, A.
    Borsellino, N.
    Verderame, F.
    Caruso, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [32] Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients
    Jimenez, Begona
    Trigo, Jose M.
    Pajares, Bella I.
    Saez, Maria I.
    Quero, Cristina
    Navarro, Victor
    Llacer, Casilda
    Medina, Laura
    Rueda, Antonio
    Alba, Emilio
    ORAL ONCOLOGY, 2013, 49 (02) : 182 - 185
  • [33] A safety and efficacy study of bleomycin sulfate and electroporation in patients with metastatic or locally recurrent breast cancer
    Paramanov, V.
    Tyurin, O.
    Polenkov, S.
    Goldfarb, P. M.
    BREAST CANCER RESEARCH, 2007, 9 (01):
  • [34] A safety and efficacy study of bleomycin sulfate and electroporation in patients with metastatic or locally recurrent breast cancer
    V Paramanov
    O Tyurin
    S Polenkov
    PM Goldfarb
    Breast Cancer Research, 9
  • [35] A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients
    Hamaguchi, Tetsuya
    Tsuji, Akihito
    Yamaguchi, Kensei
    Takeda, Koji
    Uetake, Hiroyuki
    Esaki, Taito
    Amagai, Kenji
    Sakai, Daisuke
    Baba, Hideo
    Kimura, Masami
    Matsumura, Yasuhiro
    Tsukamoto, Tetsuji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (06) : 1021 - 1029
  • [36] A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients
    Tetsuya Hamaguchi
    Akihito Tsuji
    Kensei Yamaguchi
    Koji Takeda
    Hiroyuki Uetake
    Taito Esaki
    Kenji Amagai
    Daisuke Sakai
    Hideo Baba
    Masami Kimura
    Yasuhiro Matsumura
    Tetsuji Tsukamoto
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 1021 - 1029
  • [37] Efficacy and safety of nanoparticle albumin-bound paclitaxel in taxane-pretreated metastatic breast cancer patients
    Xiong, Weili
    Xu, Ting
    Liu, Xiao
    Zhang, Lili
    Yuan, Yuan
    CANCER, 2024, 130 : 1488 - 1498
  • [38] Efficacy and Safety of Weekly Paclitaxel With or Without Oral Alisertib in Patients With Metastatic Breast Cancer A Randomized Clinical Trial
    O'Shaughnessy, Joyce
    McIntyre, Kristi
    Wilks, Sharon
    Ma, Ling
    Block, Margaret
    Andorsky, David
    Danso, Michael
    Locke, Tracy
    Scales, Amy
    Wang, Yunfei
    JAMA NETWORK OPEN, 2021, 4 (04) : E214103
  • [39] Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients.
    Jimenez, B.
    Trigo Perez, J. M.
    Saez Medina, M. I.
    Quero Blanco, C.
    Pajares, B.
    Rueda, A.
    Alba, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Efficacy and safety of polymeric micelle paclitaxel (pm-Pac) plus tislelizumab and carboplatin for first-line treatment of patients with advanced squamous non-small-cell lung cancer
    Shi, Meiqi
    Zhao, Yufang
    Wang, Li
    Peng, Wei
    Zhu, Xiangzhi
    Li, Xingwang
    Wang, Lv-Hui
    Ma, An-Mei
    Tang, Yi-Qun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345